About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
PCSK9 Inhibitors: Pharmacology, Indications, Drug Interactions, Dosing Logistics
By
Craig Beavers
4 Videos
3,539 views
September 22, 2016
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Related Content
AUTOPLAY
ON
12:04
Stephen Kopecky
Role of PCSK9 Inhibitors in Diabetes
59:01
The North American Thrombosis Forum (NATF)
Recent Cholesterol Guidelines and Integration into Clinical Practice
Feat.
J. Plutzky,
L. Braun,
J. Ross
18:43
Canadian Collaborative Research Network
Lp(a): When to Measure it and What to Do About it
Feat.
M. O'Donoghue
08:44
AHA 2022 Conference Coverage
AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…
Feat.
N. Marston
21:27
Scripps Health
Lipids Update: Current Guidelines for Lipid Management
Feat.
S. R. Mehta
14:50
AHA 2022 Conference Coverage
AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…
Feat.
K. Ray
45:45
Houston Methodist DeBakey Heart and Vascular Center
Directions of Cardiology in the Next Decade: 2022-2032
Feat.
E. Braunwald
31:02
Scripps Health
How Do I Reverse Coronary Plaque?
Feat.
C. J. Suhar
24:02
Complex Coronary Cases
Updated Lipid Guidelines and Therapy
Feat.
I. Fergus
19:48
ACC 2022 Conference Coverage
ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…
Feat.
R. Giugliano
39:44
The Texas Heart Institute
Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…
Feat.
S. Virani
33:43
Jefferson Health
Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk
Feat.
A. Cohen
25:02
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
How to Reduce Cholesterol and Triglycerides to Prevent CV Events
Feat.
P. Taub
26:32
ACC 2024 Insights
ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Don…
Feat.
S. Mora
27:12
Norman Lepor
Update on Lipoprotein A: The Horrible Cholesterol
31:50
Nadir Ali
Do Statins Prevent or Cause Heart Disease? Should LDL Be Called &quo…
06:48
Complex Coronary Cases
LIVE Round Table: Panel Discussion on Lipid Management
Feat.
R. Mehran
42:28
Houston Methodist DeBakey Heart and Vascular Center
Treatment of Lipids in 2023: Where Are We Now and Where Are We Going?
Feat.
C. Ballantyne
29:04
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
LDL-C: Earlier and Lower Is Better and Safer?
Feat.
P. Rosenblit
33:21
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
Newer Recommendations, Therapies, and Evidence for Improving Lipid C…
Feat.
N. Wong
